Centene Tops Views on Acquisition Benefits
July 26 2016 - 7:40AM
Dow Jones News
Medicaid-focused health insurer Centene Corp. on Tuesday
reported its top and bottom lines nearly doubled in the most recent
quarter, handily beating expectations, as a key measure of the
company's medical costs fell, it continued to add members and
results saw a boost from the Health Net acquisition.
Chief Executive Michael Neidorff said the Health Net integration
remains on track and "the benefits of our greater scale and
diversity are being realized accordingly."
In the quarter that ended in June, Centene's Medicaid business
again more than doubled to include 11.4 million members.
Membership, meanwhile, rose by 6.8 million from a year earlier
to 11.4 million.
Centene's medical-loss ratio, or the share of premiums paid out
for members' health expenses, shrank to 86.6% from 89.1% a year
ago.
Overall, the company posted a profit of $168 million, or 98
cents a share, up from $88 million, or 72 cents a share, a year
earlier.
The 2016 quarter included a 19-cent-a-share benefit related to
the 2015 risk adjustment and reinsurance reconciliations under the
Affordable Care Act in connection with the health insurance
marketplace business. Excluding Health Net acquisition expenses,
adjusted earnings rose to $1.29 a share from 76 cents.
Revenue shot up 98% to $10.9 billion.
Analysts were looking for adjusted earnings of $1.09 a share on
$10.79 billion in revenue.
In March, the company completed its $6.3 billion merger with
Health Net, as health insurers increasingly look for tie-ups that
can help them cut costs and grow scale. St. Louis-based Centene is
looking for the deal to boost its presence in California and other
western states.
Shares, which have added 13% over the past three months, were up
2.3% at $77.00 in premarket trading.
Write to Anne Steele at Anne.Steele@wsj.com
(END) Dow Jones Newswires
July 26, 2016 07:25 ET (11:25 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Centene (NYSE:CNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Centene (NYSE:CNC)
Historical Stock Chart
From Apr 2023 to Apr 2024